Active Ingredient History
Dextran 70 is a type of fluid given by injection into a vein to expand blood volume. Specifically it is used for shock such as that caused by bleeding or burns when blood transfusions are not quickly available. However, it does not carry oxygen. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Kidney Injury (Phase 2/Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Brain Injuries (Phase 2/Phase 3)
Brain Injuries, Traumatic (Phase 3)
Cataract (Phase 4)
Conjunctivitis, Allergic (Phase 4)
Corneal Diseases (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Endocardial Cushion Defects (Phase 2)
Heart Defects, Congenital (Phase 2)
Heart Septal Defects, Ventricular (Phase 2)
HIV Infections (Phase 1)
Keratoconus (Phase 1/Phase 2)
Lacrimal Apparatus Diseases (Phase 1)
Liver Cirrhosis (Phase 2/Phase 3)
Macular Edema (Phase 4)
Motor Neuron Disease (Phase 2)
Peritonitis (Phase 4)
Transposition of Great Vessels (Phase 2)
Uveitis, Anterior (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue